Fiona Yull
Department of Pharmacology
Department of Obstetrics and Gynecology
Program in Cancer Biology
Vanderbilt-Ingram Cancer Center (VICC)
Vanderbilt Ovarian Cancer Alliance (VOCAL)
Vanderbilt Institute for Infection, Immunology and Inflammation (VI4)
Vanderbilt Tumor Immunology Program
The research in our group is focused on understanding how inflammatory signaling contributes to the development, progression and treatment of cancers; including ovarian, breast, lung and skin. Cell culture and transgenic mouse model approaches are providing insights into effects within specific cell types and interactions between tumor and infiltrating immune cells that are informing our strategies to develop new therapies based on pharmacologic or nanoparticle approaches.
The research in our group is focused on understanding how inflammatory signaling contributes to the development, progression and treatment of cancers; including ovarian, breast, lung and skin. Cell culture and transgenic mouse model approaches are providing insights into effects within specific cell types and interactions between tumor and infiltrating immune cells that are informing our strategies to develop new therapies based on pharmacologic or nanoparticle approaches.
Keywords: Cancer , Inflammation , Nuclear Factor-kappa B , Immunotherapy , Nanotechnology , Inducible transgenic mouse models
Research Area: Drug Design , Immunology , Cancer Biology , Cancer Immunology